+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mundipharma International Ltd. - logo

MundiPharma is an Irish owned company established in 1973. There break through drug was sustained release morphine (MST® Continus® tablets). This product was seen as a major advantage in handling cancer treatment pain. MundiPharma focus on three main areas: analgesic, oncology and respiratory therapy areas. They are constantly innovating new products to help people with debilitating diseases. Mundi Pharma is part of a worldwide network of independent associated pharmaceutical companies.

From
From
Rituximab Biosimilars Global Market Report 2024 - Product Thumbnail Image

Rituximab Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • April 2024
  • 194 Pages
  • Global
From
From
From
From
From
Asthma & COPD Therapies Market Report 2023-2033 - Product Thumbnail Image

Asthma & COPD Therapies Market Report 2023-2033

  • Report
  • January 2023
  • 248 Pages
  • Global
From
Asthma Drugs Global Market Report 2024 - Product Thumbnail Image

Asthma Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Global Asthma Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Asthma Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Loading Indicator